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Cells must accurately replicate and segregate their
DNA once per cell cycle in order to successfully
transmit genetic information. During S phase in the
presence of agents that cause replication stress,
ATR-dependent checkpoints regulate origin firing
and the replication machinery as well as prevent
untimely mitosis. Here, we investigate the role of
ATR during unperturbed growth in vertebrate cells.
In the absence of ATR, individual replication forks
progress more slowly, and an increased number of
replication origins are activated. These cells also
enter mitosis early and divide more rapidly, culmi-
nating in chromosome bridges and laggards at
anaphase, failed cytokinesis, and cell death. Interest-
ingly, cell death can be rescued by prolonging
mitosis with partial inhibition of the mitotic cyclin-
dependent kinase 1. Our data indicate that one of
the essential roles of ATR during normal growth is
to minimize the level of unreplicated DNA before
the onset of mitosis.
INTRODUCTION
Replication is a complex and carefully regulated process that
must occur exactly once per cell cycle to allow successful segre-
gation of genetic material to daughter cells at cell division (Blow
et al., 2011; DePamphilis et al., 2006; Labib, 2010; Masai et al.,
2010). In higher eukaryotes, the action of the cyclin-dependent
kinase 1 (CDK1) and CDK2 protein kinases and their regulatory
cyclin partners is centrally important for progression through
the S and M phases of the cell cycle (Hochegger et al., 2008).
During S phase, cell-cycle checkpoints operate to coordinate
DNA synthesis with cell-cycle progression by negatively regu-
lating CDK complexes or regulating DNA repair or damage toler-
ance pathways (Labib and De Piccoli, 2011). These checkpoints
were first identified in yeast cells by examining survival of
mutant cells following treatment with exogenous agents thatCell Reeither damage DNA or stall DNA synthesis (Enoch et al., 1992;
Rowley et al., 1992; Weinert, 1992; Weinert and Hartwell, 1990;
Enoch and Nurse, 1990). In response to either DNA damage or
stalled replication, the so-called intra-S phase checkpoints oper-
ate entirely within S phase and lead to inhibition of origin firing
(Santocanale and Diffley, 1998; Shirahige et al., 1998; Zegerman
and Diffley, 2010), protection of stalled replication forks from
aberrant recombination (Boddy et al., 2003; Alabert et al.,
2009), relaxation of chromosomal torsional stress (Bermejo
et al., 2011), as well asmodifications of proteins at the replication
fork (De Piccoli et al., 2012). This checkpoint also contributes to
completion of replication by, for example, promoting upregula-
tion of deoxyribonucleotide (dNTP) production (Elledge et al.,
1993). By contrast, the S-M checkpoint is considered to inhibit
mitosis when replication is incomplete (Enoch et al., 1992).
The yeast kinases, Mec1 in budding yeast and Rad3 in fission
yeast, are central regulators of all DNA-structure-responsive
checkpoints described above but are also required for cell
viability (Weinert et al., 1994; Cha and Kleckner, 2002; Enoch
et al., 1992). Mec1 also facilitates DNA replication by ensuring
that dNTP pools are appropriately regulated. It achieves this by
phosphorylation of a negative regulator of ribonucleotide reduc-
tase (RNR) termed Sml1, which is subsequently degraded. This
role has long been thought to be the essential role of Mec1
because lethality of mec1-null mutants can be bypassed either
by overexpression of RNR genes or deletion of the SML1 gene
(Zhao et al., 1998). Notably, this mechanism of rescue does
not alleviate the sensitivity of these mutants to DNA-damaging
agents or chemicals that perturb replication. In addition, recent
work indicates that mec1 lethality can also be bypassed by
abrogating CDK activity demonstrating that alternative mecha-
nisms may also contribute to death following loss of this protein
(Manfrini et al., 2012).
In humans and other higher eukaryotes, the homolog of
MEC1/rad3+ is ATR, which is also an essential gene (Cortez
et al., 2001; O’Driscoll, 2009; Brown and Baltimore, 2000; Couch
et al., 2013). ATR is mutated in the human developmental disor-
der Seckel syndrome, in which individuals with homozygous
hypomorphic mutations are characterized by primordial
dwarfism and microcephaly (O’Driscoll and Jeggo, 2003;
O’Driscoll et al., 2003). Biochemical characterization of theports 5, 1095–1107, November 27, 2013 ª2013 The Authors 1095
ATR kinase shows it is recruited to single-stranded DNA and is
responsible for the activation of a downstream checkpoint
effector kinase termed CHK1 (Cimprich and Cortez, 2008). In
general terms, upon treatment of higher eukaryotic cells with
agents that damage DNA or perturb replication, ATR, similarly
toMEC1/rad3+ in yeast, stimulates S-phase-specific responses
(Lo´pez-Contreras and Fernandez-Capetillo, 2010).
Despite much information on the roles of ATR in the DNA
damage response, there is a relative paucity of work focused
on the essential role of ATR during cellular proliferation in the
absence of any exogenous agents. Given that cell lines contain-
ing hypomorphic Seckel mutations are viable yet sensitive to
DNA damage (Murga et al., 2009; Mokrani-Benhelli et al.,
2013), the essential role of ATR could be distinct from at least
some of its DNA damage checkpoint roles. Recently, DNA repli-
cation defects, including diminished progression of individual
forks, during unperturbed growth of human Seckel-derived cells
have been reported (Mokrani-Benhelli et al., 2013). However,
proliferation of Seckel cells indicates that these replication
defects do not result in lethality.
We set out to further characterize the essential role of ATR
during normal cell growth. In order to do this, we have developed
a conditional null Atr cell line using the auxin-inducible degron
(AID) and the genetically tractable and karyotypically stable
vertebrate DT40 cell line (Buerstedde and Takeda, 1991; Nishi-
mura et al., 2009). Using our AID-Atr cells, we find that depletion
of Atr in the absence of any exogenous agents results in cell
death. Loss of Atr also results in higher rates of origin firing,
although replication forks travel more slowly and have increased
failure rates. These replication defects lead to an increased fre-
quency of chromatid gaps and chromosome loss. Interestingly,
loss of Atr also results in more rapid cell cycles with an ensuing
increase of chromosomal bridges and laggards at anaphase and
an increased failure to divide properly. The cytokinesis defect
and cell death, but not chromosomal bridges and laggards,
can be rescued by subarresting concentrations of an inhibitor
of the CDK1 mitotic regulator. This treatment slows down the
cell cycle of Atr-depleted cells, resulting in mitosis being suc-
cessfully completed more frequently. Thus, during an unper-
turbed cell cycle, our data are consistent with Atr regulation of
the S-M checkpoint enforcing a minimum, although not neces-
sarily complete, threshold of replication before allowing the
onset of mitosis. We suggest that this role forms part of the
essential roles of ATR during a normal cell cycle.
RESULTS
Generation of a Vertebrate Conditional Null Atr Cell Line
We used the DT40 vertebrate model system to generate an
Atr conditional null cell line. The plant-derived AID approach
relies upon the coexpression of an AID-tagged protein and the
plant-specific F-box protein TIR1 (Nishimura et al., 2009). To
generate AID-Atr cell lines, we targeted a floxable Atr cDNA
expression cassette to the ovalbumin locus on chromosome 2,
disrupted the endogenous Atr loci, and then replaced the Atr
cDNA with the AID-Atr cDNA (Figure S1; see Supplemental
Information). Following the addition of auxin (IAA), TIR1-directed
polyubiquitination of AID-tagged Atr (AID-Atr) resulted in its1096 Cell Reports 5, 1095–1107, November 27, 2013 ª2013 The Autproteosomal degration (Figure 1A). After a 2 hr treatment with
auxin, the AID-Atr protein was no longer detectable and the
half-life of AID-Atr was determined to be approximately 15 min.
AID-Atr Can Fulfill Essential and Checkpoint Roles
Although cells without Atr initially proliferated similarly to control
cells for a time period corresponding to three cell cycles (DT40
cells have an 8 hr cell cycle), loss of Atr eventually resulted in
progressively defective cell proliferation and eventual cell death
(Figure 1B). Cell death was confirmed by measuring cell survival
following various lengths of treatment with auxin (Figure 1C).
Thus, in agreement with studies in both mouse and human cells
(Brown and Baltimore, 2000; Cortez et al., 2001; Couch et al.,
2013), Atr performs an essential role in DT40 cells. However,
unlike a cell-cycle mutant, loss of Atr does not lead to rapid
cell-cycle arrest, with most cells displaying a similar terminal
phenotype, indicating that Atr is not absolutely required for
progression through any particular period of the cell cycle.
Our AID-Atr conditional cells respond to replication stress as
expected, as when treated with hydroxyurea (HU; an inhibitor
of ribonucleotide reductase which indirectly causes replication
fork stalling), the absence of Atr resulted in loss of phosphoryla-
tion of the downstream effector kinase Chk1 at serine 345 (Fig-
ure S2C) and apoptosis was induced (Figures 1D and S2B).
Our data indicate that AID-Atr cells are proficient for Atr function
in both normally proliferating and HU-treated cells, but following
treatment with auxin, AID-Atr is rapidly proteolysed and Atr
function is lost.
Loss of Atr Leads to Uncontrolled Origin Firing
and Slow Fork Progression
To investigate the role of Atr in normally proliferating cells, we
began by examining DNA replication in the absence or presence
of Atr. Previously, the Atr downstream effector kinase Chk1 has
been implicated in maintaining DNA synthesis at individual repli-
cation forks and controlling the rates of origin firing in normally
cycling DT40 cells (Petermann et al., 2006; Maya-Mendoza
et al., 2007). To assess bulk DNA synthesis in the absence of
AID-Atr, we measured bromodeoxyuridine (BrdU) incorporation
into individual cells (Figure 2A). Flow cytometry profiles for con-
trol cells and AID-Atr cells without auxin treatment were very
similar, displaying a classic ‘‘horseshoe’’ profile corresponding
to maximal BrdU incorporation in mid-S phase cells. Auxin-
dependent degradation of AID-Atr resulted in a reproducible
(N > 10), albeit subtly different, profile with BrdU incorporation
being more uniform throughout S phase cells suggesting a
subtle change in control of bulk DNA replication in these cells.
To more carefully explore the effect of depletion of Atr on
replication dynamics, we examined replication at individual
replication forks using the quantitative DNA-combing method
(Michalet et al., 1997). Control wild-type (WT) Atr or AID-Atr
cell lines were grown with or without auxin and pulse-labeled
with iododeoxyuridine (IdU) for 20 min, followed by a 40 min
pulse with chlorodeoxyuridine (CldU), and individual DNA mole-
cules were combed onto silanized coverslips (Figure 2B). DNA
was stained with antibodies specific to IdU (red), CldU (green),
and single-stranded DNA (ssDNA) (gray) and the number of
replication forks (the number of CldU tracts) per length of DNAhors
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Figure 1. Generation of a Conditional Null
Atr Cell Line
(A) Western blotting analysis of total cell extracts
prepared from AID-Atr or WT Atr cells following
treatment with IAA (auxin) using the Atr-N19 anti-
body (Santa Cruz). The protein from the endoge-
nous Atr loci which lacks the kinase domain (see
Figure S1E) serves as a loading control.
(B) Growth analysis of cells following treatment
with IAA. Cell numbers are corrected for culture
dilution. Error bars represent the SEM from at least
three experiments.
(C) Clonogenic survival analyses of cells following
treatment with IAA for the indicated times. Values
are the mean fraction of surviving cells from two
independent experiments.
(D) Annexin V/propidium iodide (PI) flow cytometry
analysis following treatment of AID-Atr cells with
1 mMHU (4 hr) following growth in the presence or
absence of IAA (2 hr).
See also Figures S1 and S2.(determined using the ssDNA-specific antibody) quantitated
(Figure 2C). In the absence of Atr (auxin-treated AID-Atr cells),
we noticed a higher density of replicated tracts of DNA, 13.3 ±
0.73 forks/Mbp/hr compared to 8.1 ± 0.50 forks/Mbp/hr in cells
containing Atr (either the control untagged WT Atr cDNA with or
without auxin or AID-Atr cells without auxin). Thus, the absence
of Atr results in a nearly 2-fold increase in origin firing.
Next, as a measure of fork progression, we examined the
average length of CldU tracts (Figure 2D). To avoid scoring
broken DNA molecules, we measured only CldU tracts (green)
that arose from preexisting replication forks (i.e., following IdU
tracts, red) and did not correspond to the end of a DNAmolecule
(as determined using the ssDNA antibody). In the absence of Atr,
the median CldU tract length (30 kbp) was about one-third
the length of CldU tracts from cells containing Atr (85 kbp).
Thus, whereas origin firing is increased in the absence of Atr,
DNA synthesis is 3-fold less processive.
Chromosome fragility has been reported in both early and late
replicating regions (Barlow et al., 2013; Casper et al., 2002).
Furthermore, the variation in tract length observed in asynchro-
nously growing cells in the presence or absence of Atr (Figure 2D)
could indicate that individual replication forks progress at
different rates at different stages of S phase. Therefore, we
used centrifugal elutriation to fractionate asynchronously
growing cells in the absence or presence of AID-Atr and sub-
jected them to quantitative DNA combing. Different cell fractions
enriched for early S, mid S, or late S phase were obtained (Fig-
ure S3A), and measurements of CldU and IdU tract length
were made for each (Figures 2E and S3B). Consistent with our
previous observations, the same 3-fold decrease in the proces-
sivity of replication (CldU tracts) was observed in the absence of
Atr. However, this difference in tract length upon Atr depletion
could not be attributed to any specific stage of S phase.
As a measure of the tendency of forks to fail over time, we
calculated the IdU/CldU ratio of individual forks (including the
examples shown in Figure 2B). For highly processive replication,
the CldU tracts should be twice as long as IdU tracts resulting inCell Rean IdU/CldU ratio of 0.5, as was observed in the presence of Atr
(Figure 2F). However, in the absence of Atr, the IdU/CldU ratio
had a median of 0.80 (Figure 2F), indicating that CldU tracts
are only about half their expected length. Thus, in the absence
of Atr, most replication forks are prone to failing sooner and
progress more slowly (Figures 2B, 2D, and 2E).
In budding yeast, the Atr ortholog, Mec1, regulates cellular
dNTP pools during the normal cell cycle (Zhao et al., 1998). As
low dNTP levels limit replication rates (Poli et al., 2012), it is
possible that slower DNA synthesis and higher failure rates of
replication forks in the absence of Atr could result from limiting
dNTP levels. However, growth of Atr-depleted cells in the pres-
ence of additional deoxynucleosides did not alleviate death or
rescue the aberrant BrdU-incorporation profile of Atr-depleted
cells (Figures S3C and S3D).
Atr Limits Excessive Origin Firing along Individual
DNA Fibers
In the absence of Atr, we noticed that between 20% and 40% of
active replication forks occur on single tracts of DNA (around 175
kb in length) visualized as alternating IdU- and CldU-labeled
tracts of DNA (Figure 2G). These alternating tracts correspond
to 25–50 forks/Mb/hr compared to the normal density of 8
forks/Mb/hr measured in cells containing Atr (Figure 2C). This
is caused by excessive origin firing on a subset of DNA mole-
cules and may reflect a role of Atr in local control of origin firing
(Blow et al., 2011) and is consistent with models proposed from
studies using Xenopus egg extracts (Shechter et al., 2004; Mar-
heineke and Hyrien, 2004). Here, we describe this effect in DNA
molecules isolated from vertebrate cells in culture and in the
absence of any exogenous sources of DNA damage or replica-
tion stress.
Increased Chromatid Gaps and Missing Chromosomes
in the Absence of Atr
To investigate how the replication defects that result from the
absence of Atr impact upon the structure of chromosomes, weports 5, 1095–1107, November 27, 2013 ª2013 The Authors 1097
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Figure 2. Defective Replication in Atr-
Deficient Cells
(A) Cell cycle profiles of the indicated cells grown
with or without IAA for 6 hr and analyzed by flow
cytometry. DNA synthesis was measured by BrdU
incorporation and DNA content by PI staining.
(B) Representative images of combed DNA mole-
cules from cells grown in the presence or absence
of IAA. CldU tract length and IdU/CldU ratio for
each is indicated. IdU incorporation was detected
using Alexafluor 546 (red), whereas CldU was
detected using Alexafluor 488 (green). ssDNA was
detected with Alexafluor 647 (gray).
(C) Rates of origin firing in asynchronous Atr-
containing (Atr+) or Atr-depleted (Atr) cells were
calculated from the number of CldU (green) tracts
per length of DNA (gray tracts). Values were cor-
rected for the percentage of S phase cells (60%)
determined by flow cytometry. Error bars indicate
the SEM and correspond to six (Atr+) and four
(Atr) independent experiments.
(D) Rates of DNA synthesis. CldU tract lengths
were measured following a 40 min pulse with
CldU obtained from cells grown in the presence or
absence of IAA as indicated. For each condition,
CldU tract lengths were measured from at least
two independent experiments. Line and bars
indicate the median and interquartile range.
(E) Rates of DNA synthesis determined as in (D)
were measured from cell populations synchro-
nized by elutriation. CldU tract lengths from early,
middle, or late S phase cells grown in the presence
or absence of IAA are shown as indicated. For
each category, CldU tracts were measured from
DNA combed onto at least two independent
slides. Line and bars indicate the median and
interquartile range.
(F) Replication fork failure rates are shown in the
indicated cell populations. IdU/CldU ratios from
elutriated cell fractions (as in [E]) were plotted.
For each category, measurements were made
from DNA combed onto at least two independent
slides. Line and bars indicate the median and in-
terquartile range.
(G) Examples of single tracts of DNA with multiple
fired origins. All examples obtained from DNA
prepared from AID-Atr cells grown in the presence
of IAA.
See also Figure S3.examined cells at metaphase, a stage of the cell cycle when
chromosomes are fully condensed and chromosome abnormal-
ities can be readily identified. Previous reports suggest that
there is an increase in underreplicated regions of chromosomes
at metaphase following treatment with DNA polymerase inhibi-
tors in cells that lack either Atr or its kinase activity (Casper
et al., 2002).
We measured the effect of Atr loss on the chicken macrochro-
mosomes 1, 2 (triploid in DT40), 3, 4, and Z (Figure 3A) that ac-
count for about half of the genetic material in DT40 cells. Initially,
chromosome spreads were prepared from AID-Atr and WT Atr
cells grown in the presence or absence of auxin for 24 hr. In cells
containing Atr, themajority of spreads looked normal (Figure 3Ai),
with chromatid gaps and missing chromosomes occurring at a1098 Cell Reports 5, 1095–1107, November 27, 2013 ª2013 The Autvery low frequency (Figure 3B). However, after 24 hr of growth
in the absence of Atr, the occurrence of chromatid gaps,
which correspond to unreplicated DNA, increased 20-fold to
approximately one gap per spread (Figures 3Aii, 3Aiii, and 3B).
The increase in chromatid gaps is time-dependent (Figure 3C).
In addition, absence of Atr resulted in a time-dependent increase
in the occurrence of spreads with missing chromosomes (Fig-
ure 3C). The low level of missing chromosomes at 8 hr suggests
that chromosome loss is dependent upon passage through at
least one cell cycle after loss of Atr. Among the spreads prepared
from cells grown in the absence of Atr, we also noticed a signif-
icant occurrence of spreads (about 8%; see Figure 3Aiv) with
too many abnormalities to accurately score, and these were
not included in further analyses. It is of interest to note thathors
AB C
Figure 3. Increased Chromosome Loss and
Chromatid Gaps following Atr Depletion
(A) Examples of metaphase spreads prepared
from cells containing Atr (i) and Atr-depleted cells
(ii)–(iv). Chromosome gaps are indicated with
white arrowheads. An example of a spread with
multiple chromosome gaps and fragments
following depletion of Atr is shown in (iv).
Expanded view of representative chromatid gaps
are shown in (iii).
(B) Quantification of chromatid gaps. The average
number of gaps per metaphase spread following
24 hr growth in the presence or absence of IAA is
shown. Values are the average of three experi-
ments with at least 150 spreads scored per con-
dition. Error bars represent the SEM.
(C) Quantification of chromosome gaps and
missing chromosomes per spread over time
following growth in the presence or absence of IAA
as indicated. Values are the average of three ex-
periments with at least 150 spreads scored per
condition. Error bars represent the SEM.
See also Figure S4.metaphase spreads with extra chromosomes were very rarely
(<1%) observed and radial chromosome structures, associated
with defects in homologous recombination (Patel et al., 1998),
were never detected.
Because a misfunctioning spindle assembly checkpoint (SAC)
could lead to an increase in chromosome loss, through lost
attachment and alignment of chromosomes at metaphase
(Varetti and Musacchio, 2008), we decided to address the role
of Atr in this checkpoint by measuring nocodazole/Taxol-
induced mitotic arrest (Figure S4). In the absence of Atr, we
observed no defect in the efficiency of mitotic arrest. Treatment
of cells with the Chk1 inhibitor, UCN-01, abrogatedmitotic arrest
after both nocodazole and taxol consistent with the reported
role for Chk1 in the SAC (Zachos et al., 2007). Thus, despite
the close functional relationship between Atr and Chk1 with
respect to DNA structure checkpoints, Atr, unlike Chk1, appears
to be dispensable for SAC function. Our data suggest that the
chromosome loss observed in the absence of Atr cannot be
a result of a loss of SAC function but rather some other mecha-
nism most likely linked to the incomplete replication of chromo-
somes observed in these cells.
Loss of Atr Leads to More Rapid Passage through
the Cell Cycle
While studying nocodazole and taxol arrests, we noticed that
Atr-depleted cells accumulated in mitosis more rapidly (Fig-
ure S4). Therefore, we decided to measure the rate of passageCell Reports 5, 1095–1107, Nothrough the cell cycle following depletion
of Atr in more detail. The accumulation of
mitotic cells upon addition of nocodazole
in the absence of Atr was about 1 hr faster
than in the presence of Atr (Figures 4A,
S5A, and S5B). We also monitored cell-
cycle progression in the presence or
absence of Atr by pulse-labeling S phasecells with BrdU and then monitoring DNA content (propidium
iodide [PI] signal) of the BrdU-positive cells at regular time
intervals during the BrdU chase period (Figure S5C and S5D).
In the absence of Atr, the cells divided about 1 hr faster than
cells containing Atr (Figure 4B), consistent with the mitotic accu-
mulation experiment (Figure 4A). Thus, prior to their eventual cell
death (Figure 1B), conditional removal of Atr initially results in
more rapid cell cycles, specifically an advancement of mitosis
relative to S phase.
Atr Depletion Leads to Mitotic Defects
We were particularly interested in determining whether the repli-
cation defects associated with loss of Atr might be compounded
by faster progression through the cell cycle. To examine this in
more detail, we initially used immunofluorescence microscopy
of fixed cells (Figure 4C). The absence of Atr led to an increase
in aberrant mitotic events, such as chromosome bridges and
lagging chromosomes, as well as cell division defects that re-
sulted in the appearance of micronuclei or binuclear cells caused
by a complete failure in cytokinesis. We then looked in AID-Atr
cells expressing PLK1-interacting checkpoint helicase (PICH)-
EGFP to observe the occurrence of DNA ultrafine anaphase
bridges (UFBs) (Chan et al., 2007) in the presence or absence
of Atr (Figure 4D). UFBs facilitate segregation of unreplicated
DNA at anaphase (Lukas et al., 2011).
To gain a better understanding of the cumulative effect of
these problems, we next visualized cells with and without Atrvember 27, 2013 ª2013 The Authors 1099
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(A) Mitotic accumulation assay. Histone H3S10ph
accumulation in the presence of nocodazole was
plotted for the indicated cells grown in the pres-
ence or absence of IAA. The flow cytometry data
are shown in Figure S5A. Values are the average
of at least three experiments. Error bars represent
the SEM.
(B) Cell-cycle progression. The indicated cells
grown in the presence or absence of IAA were
analyzed for cell-cycle position after BrdU pulse
chase. The flow cytometry data are shown in Fig-
ure S5C. Values are the average of at least four
experiments. Error bars represent the SEM.
(C) Immunofluorescencemicroscopy of fixed cells.
Representative mitotic abnormalities following
depletion of Atr are indicated by white arrow-
heads. Spindles were visualized with antitubulin
antibody (green) and DNA visualized using DAPI
(blue). The scale bar represents 5 mm.
(D) Fluorescence microscopy of fixed cells con-
taining PICH-EGFP (green). Representative early
and late mitotic cells containing PICH UFBs. DNA
was visualized using DAPI (blue). The scale bar
represents 5 mm.
(E) Mitotic abnormalities in live cells. Selected
frames from time-lapse movies of indicated cells
grown in the presence or absence of IAA for 8–14 hr
are shown. Mitosis was visualized using H2B-RFP
and matched with bright-field (BF) images to
visualize cytokinesis. Examples shown are normal
mitosis in cells containing Atr (i), Atr-depleted cells
showing aDNAbridge at anaphase (ii), Atr-depleted
cells showing a lagging chromosome at anaphase
(iii), and Atr-depleted cells showing a DNA bridge
at anaphase with the cell subsequently becoming
binuclear (iv). The scale bar represents 5 mm.
(F) Quantification of mitotic abnormalities. Per-
centage of mitotic cells recorded by time-lapse
microscopy displaying the indicated abnormalities
following growth in the presence or absence of
IAA were plotted as indicated. Values represent
the average of three independent experiments
with 128 (Atr+) and 171 (Atr) cells analyzed. Error
bars represent the SEM.
(G) Quantification of PICH UFBs in early and late anaphase cells. Percentage of mitotic cells containing PICH UFBs following growth in the presence or absence
of IAA were plotted as indicated. Values are the average of four independent experiments with 86 early and 109 late anaphase (Atr+), 112 early and 109 late
anaphase (Atr 8 hr), and 94 early and 123 late anaphase (Atr 24 hr) cells analyzed. Error bars represent the SEM.
(H) Quantification of binucleate cells. Percentage of cells recorded by time-lapse microscopy grown in the presence or absence of IAA displaying normal division
or binucleate morphology. Values are the average of three independent experiments with 128 (Atr+) and 171 (Atr) cells analyzed. Error bars represent the SEM.
See also Figure S5.using live-cell microscopy and paying particular attention to
chromosome segregation. A stable AID-Atr cell line expressing
monomeric red fluorescent protein (RFP)-tagged human histone
H2B (Dodson et al., 2007) and EGFP-tagged human proliferating
cell nuclear antigen (PCNA) (Essers et al., 2005) was generated
to monitor chromatin condensation, replication foci, and nuclear
envelope breakdown in live cells. Most cells containing Atr
passed through mitosis and divided successfully (Figure 4Ei)
with only approximately 5% displaying signs of chromosome
segregation problems, such as lagging chromosomes or chro-1100 Cell Reports 5, 1095–1107, November 27, 2013 ª2013 The Autmosome bridges (Figure 4F). However, when Atr was depleted
from cells for between 8 and 14 hr, up to 40% of cells experi-
enced chromosome segregation problems at the onset of
anaphase (Figures 4Eii–4Eiv and 4F; Movie S1). In addition to
these chromosome segregation problems, we quantified the
presence of DNA UFBs in our cell line expressing PICH-EGFP
(Figures 4D and 4G). We looked in early and late anaphase
cells (determined by the distance between the segregating
chromosomes) and found that there was an increase in the
occurrence of UFBs in mitotic cells in the absence of Atr.hors
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Figure 5. DNA Replication in Condensed
Chromatin following Depletion of Atr
(A) Microscopic assessment of DNA synthesis in
fixed cells. Sites of DNA synthesis were deter-
mined by incorporation of EdU (red) into DNA
(blue) of cells grown in the presence or absence of
IAA as indicated. The scale bar represents 5 mm.
(B) Recruitment of EGFP-PCNA (green) foci to
mitotic DNA (blue) in the indicated cells grown in
the presence or absence of IAA. The scale bar
represents 5 mm.
(C) Microscopic assessment of replication foci in
live cells. Chromatin was visualized using H2B-
RFP and sites of presumptive DNA synthesis
visualized using EGFP-PCNA in the indicated cells
grown in the presence or absence of IAA. Times in
minutes are indicated and represent the time
before onset of chromatin condensation, which
was set as zero. The scale bar represents 5 mm.
(D) Quantification of time between loss of replica-
tion foci and the beginning of chromosome
condensation. The time taken between loss of
EGFP-PCNA foci and the first appearance of
condensed chromatin was recorded for individual
cells grown in the presence or absence of IAA as
indicated was plotted. Line and bars indicate the
median and interquartile range with measure-
ments taken from three independent experiments
with 69 (none) and 122 (+IAA) cells analyzed.Additionally, in cells containing Atr, there were fewer UFBs at late
anaphase compared to early anaphase reflecting successful res-
olution as anaphase progresses as described in previous studies
(Chan et al., 2007). Interestingly, even in the absence of Atr, there
were relatively fewer UFBs in late compared to early anaphase
cells suggesting that UFB resolution is not absolutely dependent
upon Atr. However, without Atr, up to 50% of the cells still
contain one or two UFBs approaching the end of mitosis (Fig-
ure 4G), suggesting that Atr facilitates UFB resolution.
Finally, in our live-cell experiment, bright-field analyses of cells
after anaphase demonstrated that approximately 35% of cells
were unable to complete cytokinesis resulting in the formation
of binuclear cells (Figures 4Eiv and 4H; Movie S1). Close to
20% of the cells in mitosis displayed either anaphase bridges
or lagging chromosomes before becoming binuclear cells (Fig-
ure S5E). Our data indicate that conditional removal of Atr results
in significant mitotic defects in chromosome segregation that
ultimately leads to cell division failures.Cell Reports 5, 1095–1107, NoReplicationOverlapswithMitosis in
the Absence of Atr
A recent publication highlighted the
damaging consequences of replication
during the G2/M phases of the cell cycle
(Crasta et al., 2012). Interestingly, in
the absence of Atr, focal incorporation
of ethynyldeoxyuridine (EdU) (a thymidine
analog) during a brief 10 min pulse was
observed in highly condensed mitotic
chromatin in 20% of mitotic cells,
although never when Atr was present(Figures 5A and S5F). We confirmed this result by observing
EGFP-PCNA foci in condensed chromatin in the absence of
Atr (Figure 5B; note that EGFP-PCNA replication foci are weaker
than EdU foci). Furthermore, in this case, the presence of EGFP-
PCNA is direct evidence for this component of the DNA synthesis
machinery in condensed chromatin only when Atr is absent.
To support the incorporation of EdU and focal localization of
EGFP-PCNA into condensed mitotic chromatin in the absence
of Atr in fixed cells, we used live-cell microscopy to monitor
the time between nuclear envelope breakdown/chromatin
condensation and disappearance of EGFP-PCNA foci (Figures
5C and 5D). In Atr-containing cells, EGFP-PCNA foci disap-
peared with a median time of 140 min before initiation of DNA
condensation (Figures 5C and 5D; Movie S2). However, in the
absence of Atr, the length of time between the loss of detectable
EGFP-PCNA foci and the onset of chromosome condensation
was considerably shorter with a median time of 80 min (Figures
5C and 5D; Movies S2 and S3). In 6.5% (8/122) of Atr-depletedvember 27, 2013 ª2013 The Authors 1101
cells, EGFP-PCNA foci were apparent right up to the point
of chromosome condensation (Figure 5D; data points at
0 min). Moreover, EGFP-PCNA foci sometimes persist after
chromosome condensation has occurred in Atr-depleted cells
(Movie S4).
Our data are consistent with Atr-depleted cells struggling to
complete replication before the onset of chromosome con-
densation and that low levels of replication may even continue
into mitosis. In extreme cases, this is likely to lead to multiple
chromosomal aberrations at mitosis, consistent with our meta-
phase spread analyses (Figure 3Aiv). In less extreme cases, this
may lead to missegregation of single chromosomes to micronu-
clei as observed by microscopy (Figure 4C). In Atr-proficient
cells, entry into mitosis is prevented while DNA replication is
ongoing.
Cdk1 Inhibition Partially Rescues Atr-Deficient Cells
A recent study in S. cerevisiae has demonstrated that the cdc28-
as1 mutation, encoding a mutant version of the major yeast
cyclin-dependent kinase (CDK) with reduced kinase activity,
can rescue the lethality of cells harboring a null mutation in
MEC1 (Manfrini et al., 2012). The authors suggest that lower
CDK activity leads to a slower cell cycle that contributes to better
survival of mec1D mutants. We used RO3306, a CDK inhibitor
specific for the mitotic regulator, Cdk1, to determine if partial
inhibition of Cdk1 could rescue the lethality of Atr depletion. As
expected from previous studies (Steere et al., 2011), RO3306
functions in DT40 cells because 10 mM RO3306 prevented
mitotic entry (Figure S6A). However, at 2.5 mM RO3306, the
cell cycle profile was essentially the same as untreated cells
showing normal mitotic entry.
Cell proliferation and long-term viability in the absence of Atr
was significantly rescued by 2.5 mM RO3306, a concentration
of RO3306 that had little effect on growth of control cells (Figures
6A and 6B). Rescue of the lethality after loss of Atr by RO3306
was not complete suggesting that some events that cause cell
death in the absence of Atr might not be rescued by partial
inhibition of Cdk1.
Prolongation of the Cell Cycle by Cdk1 Inhibition
Facilitates Cytokinesis in Atr-Depleted Cells
The limiting concentrations of theCdk1 inhibitor usedwere insuf-
ficient to cause a cell-cycle arrest but might affect the overall
length of the cell cycle providing more time to complete replica-
tion and thus rescuing the lethality of Atr-deficient cells. To inves-
tigate this hypothesis, wemonitored cell-cycle progression in the
presence of 2.5 mM RO3306. The faster progression through the
cell cycle in the absence of Atr was rescued by the RO3306 treat-
ment (Figure 6C).
To further characterize the mechanism of rescue by RO3306,
we used live-cell microscopy to determine if any of the abnormal
mitotic phenotypes we observed in the absence of Atr were
rescued. RO3306 did not significantly rescue the increased
occurrence of chromosome bridges and lagging chromosomes
during anaphase in cells lacking Atr (Figure 6D). Nor did it
rescue the shortened median time between nuclear envelope
breakdown/chromatin condensation and disappearance of
EGFP-PCNA foci (Figure 6E). However, RO3306 did rescue the1102 Cell Reports 5, 1095–1107, November 27, 2013 ª2013 The Autformation of binucleate cells in the absence of Atr to levels similar
to that of untreated cells (Figure 6F).
As a further control, we examined rates of DNA replication of
individual forks in the presence or absence of 2.5 mM RO3306
using the DNA-combing method (Figure S6C). We found that
low rates of synthesis at individual forks in Atr-depleted cells
were not rescued by the presence of RO3306.
These observations suggest that, whereas partial inhibition of
Cdk1 does not rescue the replication defects or chromosome
segregation defects associated with loss of Atr, it does allow
successful cell division.
DISCUSSION
We have developed a conditional null Atr vertebrate cell line
using an auxin-inducible degron approach in the DT40
model system. The efficient and rapid loss of the protein
following treatment of cells with auxin has allowed us to care-
fully analyze the immediate effects of the loss of Atr during an
unperturbed cell cycle. We found that the loss of Atr does not
result in cell-cycle arrest nor does it result in immediate cell
death. Rather, defective replication and advanced mitosis
lead to chromosome missegregation that culminates in even-
tual cell death. In Atr-depleted cells, the rate of replication
origin firing is increased 2-fold, replication forks synthesize
DNA 3-fold more slowly, and many forks are more likely to
fail prematurely. Similar replication defects have been reported
in Chk1/ cells (Maya-Mendoza et al., 2007; Petermann et al.,
2006) and more recently in cells treated with an Atr inhibitor
(Couch et al., 2013). This is reminiscent of early work with
Mec1, the budding yeast ortholog of Atr, and is consistent
with roles at replication forks for both Atr and Mec1 during un-
perturbed cellular proliferation (Labib and De Piccoli, 2011; Cha
and Kleckner, 2002).
Interestingly, recent characterization of a new ATR hypomor-
phic Seckel patient used DNA combing to report very similar
replication defects to those we have shown in DT40 cells
(Mokrani-Benhelli et al., 2013). Given that Seckel patients survive
to adulthood (albeit with severe abnormalities) and that Seckel
cells are able to proliferate normally in cell culture, this raises
the possibility that maintenance of efficient replication by the
ATR-dependent intra-S checkpoint, although vitally important
for cells when exogenous stresses occur, is not the only impor-
tant role of ATR.
Additionally, our identification of regions of especially dense
origin firing within a subset of the DT40 genome during unchal-
lenged growth in the absence of Atr is also consistent with a
role for Atr in suppressing origin firing as shown previously in
Xenopus extracts (Marheineke and Hyrien, 2004; Shechter
et al., 2004). These origin-dense regions may represent groups
of licensed origins or replication factories (Sanchez-Pulido
et al., 2010; Zegerman and Diffley, 2007; Mantiero et al., 2011;
Ge and Blow, 2010) that, in the absence of ATR, are all fired
uncontrollably. Alternatively, they may represent difficult to repli-
cate regions of the genome in which forks fail or stall at high
frequency and require ATR to prevent firing of ectopic origins.
Our results would also be consistent with an indirect effect of
loss of ATR on origin firing. In this situation, origins may firehors
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Figure 6. Partial Inhibition of Cdk1 Partially
Rescues Cell Death following Depletion
of Atr
(A) Growth analysis of cells following treatment
with IAA in the presence or absence of 2.5 mM
RO3306. Cell numbers are corrected for culture
dilution. For the AID-Atr cells, values represent the
mean of four experiments and error bars represent
the SEM. For theWT Atr cells, values represent the
mean of two experiments.
(B) Clonogenic survival analyses of cells following
treatment with IAA for the indicated times in the
presence or absence of 2.5 mM RO3306. Values
are the mean fraction of surviving cells from at
least three independent experiments. Error bars
represent the SEM.
(C) Cell-cycle progression. The indicated cells
grown in the presence or absence of IAA and/or
RO3306 were analyzed for cell-cycle position after
BrdU pulse chase. For the AID-Atr cells, values
represent the mean of four experiments and error
bars represent the SEM. For the WT Atr cells,
values represent the mean of two experiments.
(D) Quantification of mitotic abnormalities.
Percentage of mitotic cells recorded by time-
lapse microscopy displaying the indicated
abnormalities following growth in the presence or
absence of IAA and/or RO3306 were plotted as
indicated. Values represent the average of three
independent experiments. Error bars represent
the SEM.
(E) Quantification of time between loss of repli-
cation foci and beginning of chromosome
condensation. The time taken between loss of
EGFP-PCNA foci and the first appearance of
condensed chromatin was recorded for individual
cells grown in the presence or absence of IAA
and/or RO3306 as indicated was plotted. Line
and bars indicate the median and interquartile
range with measurements taken from three
independent experiments with 69 (none), 122
(+IAA), 57 (RO3306), and 81 (IAA and RO3306)
cells analyzed.
(F) Quantification of binucleate cells. Percentage
of cells recorded by time-lapse microscopy grown
in the presence or absence of IAA and/or
RO3306 displaying normal division or binucleate
morphology. Values are the average of three independent experiments with 128 (none), 171 (+IAA), 97 (RO3306), and 144 (IAA and RO3306) cells analyzed. Error
bars represent the SEM.
Note that data for cell lines grown in the absence of RO3306 in (C–F) are the same as shown in previous figures and plotted again here for ease of comparison.
See also Figure S6.because passive replication of dormant origins is less efficient
due to lower rates of DNA synthesis.
We propose that an essential role of ATR is tomaintain a timely
cell cycle, specifically to prevent premature entry into mitosis.
Similar conclusions have recently been drawn from the use of
a hypomorphic allele ofCDC28, themajor CDK of budding yeast,
to rescuemec1D cells (Manfrini et al., 2012). We have seen that,
in the absence of Atr, cells initially progress into mitosis more
rapidly and there is a significant overlap between replication
and mitosis. This is consistent with a role for Atr in regulating
the transition between DNA synthesis and chromosome segre-
gation during normal cellular proliferation. Such an S-M check-Cell Repoint could enforce completion of DNA replication before cell
division occurs and was originally demonstrated to prevent
mitosis in the presence of replication forks stalled by HU
treatment (Enoch and Nurse, 1990). We find that loss of Atr
immediately results in premature mitosis, increased chromo-
some bridges and laggards at anaphase, and, ultimately, failed
cytokinesis, presumably because of chromatin bridging through
the cleavage furrow.
Recent data indicate the presence of mechanisms in normally
growing higher cells that ensure segregation of chromosomes
during anaphase despite the chromosomes not being fully repli-
cated (Chan et al., 2007, 2009; Lukas et al., 2011). Unreplicatedports 5, 1095–1107, November 27, 2013 ª2013 The Authors 1103
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Figure 7. Model Highlighting the Impor-
tance of the ATR-Regulated S-M Check-
point during Normal Cell Growth
(A–C) The S-M checkpoint prevents the onset of
mitosis when DNA replication is ongoing but is not
sensitive to low levels of unreplicated DNA, which
is dealt with in mitosis by dissolution pathways.
Cell cycle schematics are shown for WT ATR cells
(A), ATR-deficient cells (B), and ATR-deficient
cells with delayed mitotic progression (C). Note
that, in the absence of ATR, the time required for
dissolution exceeds the duration of mitosis (see
text for details). The schematic above the cell-
cycle phase diagrams indicates cells from meta-
phase to cytokinesis but excludes earlier phases
of chromosome condensation. An anaphase
bridge and a binucleate cell are indicated in (B).
Note that CDK1 partial inhibition does not
completely rescue cell death in the absence of
ATR suggesting that other mechanisms that do
not involve cytokinesis failure can also cause cell
death.DNA is resolved during anaphase in structures termed ultrafine
bridges by the Bloom’s syndrome helicase (BLM)/topoiso-
merase IIIa/hRMI1 complex in a process termed dissolution.
Our data suggest that, although Atr is not absolutely required
for dissolution to occur, it is required for the efficiency of disso-
lution. UFB-dependent DNA processing during anaphase
appears to be particularly important to allow cell-cycle
progression in the presence of chromosomal regions of incom-
plete replication, for example, common fragile sites correspond-
ing to regions of low origin density (Debatisse et al., 2012;
Letessier et al., 2011) or early replication fragile sites where
DNA synthesis is inefficient (Barlow et al., 2013).
We propose that, in the absence of Atr, unreplicated DNA
normally present during mitosis is increased sufficiently to
overwhelm dissolution pathways (see Figure 7). Excess unrepli-
cated DNA at mitosis resulting from loss of ATR-dependent
replication control during S phase would be exacerbated by
premature advancement into mitosis which in turn results in
cytokinesis failure and eventual cell death (Figure 7B). The pro-
liferation of Seckel cells despite their loss of replication control
during S phase suggests that it is premature advancement into
mitosis that results in cell death when Atr is absent. In the
absence of Atr, we observed that subarresting inhibition of
Cdk1, which slows mitotic progression (Mathieu et al., 2013),
resulted in successful completion of cytokinesis and rescued
cell death (Figure 7C). Under these conditions, prolonged
mitosis would allow dissolution pathways the extra time
required to deal with unreplicated DNA. We reason that addi-
tional unreplicated DNA in the absence of Atr is not a problem1104 Cell Reports 5, 1095–1107, November 27, 2013 ª2013 The Authorsitself but rather a problem when cells
enter mitosis prematurely due to loss of
the S-M checkpoint. We suggest that,
in higher cells, at least part of the essen-
tial function of ATR is to ensure that a
minimum threshold of replication has
been completed before mitotic entry.Thus, this S-M checkpoint allows cell-cycle progression in the
presence of small amounts of unreplicated DNA, which can
be segregated during mitosis by dissolution (Chan et al.,
2007, 2009) and dealt with in the next cell cycle (Lukas et al.,
2011).
Partial inhibition of Cdk1 did not completely rescue cell death
suggesting that there could be other factors contributing to cell
death that cannot be solved by merely extending mitosis. We
have also observed an increased occurrence of micronuclei
and an increase in chromosome loss following loss of Atr.
Inefficient replication within micronuclei has recently been
reported to result in chromosome fragmentation (Crasta et al.,
2012). Whatever the mechanism, chromosome loss results in
the loss of genetic information and cell death in daughter cells.
Over the years, a major focus for targeted cancer therapies
has been cyclin-dependent kinases (Cicenas and Valius, 2011;
Malumbres et al., 2008). However, our findings suggest that
targeting these kinases may not be ideal unless high levels of
inhibition can be achieved in the target cells. Our data suggest
that, at suboptimal concentrations, some CDK inhibitors might
alleviate the death of cells suffering replication stress, thereby
resulting in increased genome instability and promoting tumor
progression. This may be a generally applicable consideration
for cancer therapeutic strategies that target cell-cycle progres-
sion. Cancer therapeutics that result in some cell death even at
limiting doses would be preferable to those whose therapeutic
benefit is reversed at suboptimal doses. At least for cancers dis-
playing oncogene-induced replication stress, inhibition of pro-
teins, such as ATR, required for cells to cope with replication
stress might represent better targets than some cell-cycle inhib-
itors. Indeed, even partial loss of ATR has been reported to result
in some cell death in cells suffering replication stress (Murga
et al., 2011; Toledo et al., 2011).
EXPERIMENTAL PROCEDURES
Cell Culture
DT40 cell lines were cultured at 39.5C and 5.0%CO2 under humidified condi-
tions in RPMI 1640 (with L-glutamine), 10% fetal bovine serum, 1% chicken
serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. Media and supple-
ments were obtained from either Sigma-Alrdich or Lonza. For cell proliferation
analysis, cultures were seeded at a density of 0.1 3 106 cells/ml and counted
using a hemocytometer every 24 hr. Exponential growth was maintained
(between 0.1 and 1.0 3 106 cells/ml) by appropriate dilution in fresh medium
every 24 hr. Survival of cells following treatment with IAA was determined by
clonogenic survival assays in methylcellulose medium. Colonies formed by
surviving cells were counted 7–10 days after treatment and plating in themeth-
ylcellulose medium. Transfection was performed by electroporation of 1.0 3
107 cells with 10–15 mg linearized plasmid using 0.4 cm Gene Pulsar cuvettes
and Gene Pulsar electroporation apparatus (Bio-Rad) at 550 V and 25 mF.
Selection was performed using G418 (InvivoGen; 2 mg/ml), histidinol (Sigma-
Aldrich; 1 mg/ml), puromycin (InvivoGen; 0.5 mg/ml), blasticidin (InvivoGen;
25 mg/ml), and hygromycin (InvivoGen; 2 mg/ml). Auxin (IAA; Sigma-Aldrich)
was prepared at 0.5 M in ethanol; it was prepared fresh for each experiment
and used at a final concentration of 0.5 mM. Hydroxyurea (Sigma-Aldrich)
was prepared at 0.66 M in water and used at a concentration of 1 mM. Noco-
dazole (Sigma-Aldrich) was prepared in DMSO at a concentration of 2 mg/ml
and used at 0.25 mg/ml. Taxol (paclitaxel; Sigma-Aldrich) was prepared in
DMSOata concentration of 10mMandusedat 10mM.UCN-01 (Sigma-Aldrich)
was prepared in DMSO at a concentration of 1 mM and used at 1 mM. RO3306
(Calbiochem) was prepared in DMSO at a concentration of 10mM. Unless
otherwise stated, all chemicals and drugs were stored at 20C.
Plasmid and Cell Line Construction
Ovalbumin- and Atr-targeting plasmids as well as cDNA expression plasmids
of Atr, AID-Atr, TIR1-9myc, and EGFP-PCNA were constructed for this study
and are detailed in the Supplemental Information. Details of construction of
the conditional AID-Atr cell lines, including those expressing fluorescent
H2B-RFP, EGFP-PCNA, and PICH-EGFP, are provided in the Supplemental
Information.
SDS-PAGE and Western Blotting
For western analysis of Atr protein, total cell extracts were run on SDS-PAGE
gels with 6.5% acrylamide and 80:1 acrylamide:bis-acrylamide. Atr-N19
antibody (Santa Cruz Biotechnology) was used at final dilution of 1:2,000 in
5% fat-free milk in PBS containing 0.1% Tween-20 with overnight incubation
at 4C. Horseradish peroxidase-linked anti-goat secondary antibody (Santa
Cruz) was used at 1:5,000 in 5% fat-free milk PBS/0.1% Tween with 1 hr
incubation. Chemiluminescent detection was performed using an ECL kit
according to the manufacturer’s instructions (Amersham).
Annexin V/PI Assay
Cells were seeded at a density of 0.13 106 cells/ml 24 hr before treatment, and
the following day, they were subjected to the relevant treatments. About 2 3
106 cells were resuspended in 50 ml of calcium chloride buffer (10 mM 4-(2-hy-
droxyethyl)piperazine-1-ethanesulfonic acid [HEPES] pH 7.5, 140 mM NaCl,
2.5 mM CaCl2) containing 1 ml of annexin V-fluorescein isothiocyanate (FITC)
peptide and left at room temperature for 15 min. Three hundred microliters of
calcium chloride buffer containing 660 ng/ml propidium iodide was then
added. Samples were thenmeasured using a fluorescence-activated cell-sort-
ing (FACS) Canto II flow cytometer and analyzed using BD FACSDiva software.
Fixed Cell Flow Cytometry
In all cases, approximately 1.0 3 106 cells were fixed in cold PBS and 70%
ethanol and stored at 4C. For analysis, cells were first washed in 1 ml PBSCell Recontaining 1% BSA, then resuspended in 50 ml PBS with 1% BSA and 0.1%
Triton X-100 containing rabbit anti-H3S10ph (Millipore) diluted 1:50 or mouse
anti-BrdU (Becton Dickinson) diluted 1:20, and then left for 1–2 hr. The cells
were then washed twice in 1 ml of PBS containing 1%BSA. then resuspended
in 50 ml PBS with 1% BSA and 0.1% Triton X-100 containing goat anti-rabbit-
FITC (Jackson Immunoresearch Laboratories) diluted 1:100 or goat anti-
mouse-FITC (Jackson Immunoresearch) diluted 1:100, and then left for 1 hr.
The cells were then washed twice in 1 ml of PBS containing 1% BSA and
resuspended in 300 ml of PBS containing 40 mg/ml propidium iodide (Sigma-
Aldrich) and 250 mg/ml RNaseA (Qiagen). Samples were then measured using
a FACS Canto II flow cytometer and analyzed with BD FACSDiva software.
BrdU Pulse-Chase Experiment
Cells were grown to a density of approximately 0.5 3 106 cells/ml and then
pulse treated with 20 mM BrdU for 20 min before washing twice with 5 ml of
PBS and splitting into two separate flasks. To one flask, 0.5 mM IAA was
added. Samples were taken and fixed at time intervals following the pulse
with BrdU as indicated.
DNA Combing
Cells were plated at a density of 0.1 3 106 cells/ml 24 hr before treatments.
Following relevant treatments, cells were incubated with 25 mM IdU for
20 min and then 200 mM CldU for 40 min, and finally, 1 mM of thymidine was
added to stop incorporation of CldU. DNA was combed essentially according
to published protocols (Michalet et al., 1997), and a comprehensive method
(including antibodies used) can be found in the Supplemental Information.
Fractionation of Cells by Elutriation
Approximately 2 3 108 cells from exponentially growing asynchronous cell
cultures were separated using a Beckman JE-6B elutriating rotor system. Cells
were loaded onto the rotor in growth medium at room temperature at a flow
rate of 40 ml/min and rotor speed of 4,000 rpm. The cells were eluted by
reducing the rotor speed in 200 rpm increments between 3,800 rpm and
2,200 rpm. The cell fractions were analyzed by flow cytometry to determine
the cell-cycle phase.
Metaphase Spreads
Before fixation, between 1–5 3 106 exponentially growing cells were
treated with 0.1 mg/ml colcemid for 1 hr. The cells were collected and
resuspended in 5 ml of hypotonic solution (75 mM KCl) and incubated for
10 min at 37C. The cells were resuspended in 5 ml of cold fixative
(methanol/acetic acid; 3:1) and incubated for 20 min at 37C. This fixation
step was repeated and cells resuspended in approximately 200 ml of fixative
solution. Cells were stored at 20C. For spreading, 50 ml of fixed cells were
dropped onto prewet (50% ethanol) polysine slides and air dried. Chromo-
someswere stained for 20min in GURR buffer containing 3%Giemsa solution.
A light microscope with a 1003 objective was used to visualize chromosome
spreads.
Immunofluorescence
Cells were attached to poly-L-lysine-coated slides, fixed in 4% paraformalde-
hyde for 10min, and permeabilized with 0.125% Triton X-100 in PBS for 2 min.
Cells were blocked for 1 hr at room temperature in 1% BSA in PBS. Cells were
incubated with a monoclonal a-tubulin (B512; Sigma) primary antibody at
1:2,000 at 37C followed by a 45 min incubation with FITC-conjugated
secondary antibody (Jackson Immunoresearch). Slides were mounted with
Vectashield (Vector Laboratories) supplemented with 1 mg/ml DAPI. For incor-
poration and detection of EdU, cells were grown in the presence of 20 mMEdU
for 10 min before fixation. Cells were stained with DAPI to detect DNA, and the
presence of EdU was detected using a tetramethylrhodamine isothiocyanate
fluorescein according to the manufacturer’s instructions (Click-iT, Invitrogen).
Images were acquired using a Delta Vision integrated microscope system
(Applied Precision) controlled by SoftWorx software mounted on an IX71
Olympus microscope with a PlanApo N603 oil objective (numerical aperture
[NA] 1.40). Images were deconvolved using the ratio method and maximal
intensity projections obtained using softWoRx.ports 5, 1095–1107, November 27, 2013 ª2013 The Authors 1105
Live-Cell Imaging
For live-cell imaging, AID-Atr cells were stably transfected with two plasmids
encoding pH2B-RFP (Dodson et al., 2007) and pEGFP-PCNA. Treated and
control cells were placed in ibiTreat 8-well m-slides (Ibidi) for 2 hr, and media
was supplemented with 12.5 mM HEPES, pH7.5 before imaging. Time-lapse
images were recorded every 5 min for 6 hr on an integrated DeltaVision micro-
scope system controlled by softWoRx software (Applied Precision) using a
PlanApo N603 oil objective (NA 1.42) and maintained at 39.5C in an environ-
mental chamber (WeatherStation; Precision Control).
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